The brain of deceased AD patients showed activated UPR expressing chaperone Grp78 (Hoozemans et al., 2005), and immunohistochemical evidence of PERK and eIF2α activation (Unterberger et al., 2006; Scheper and Hoozemans, 2015). Here, EIF2AK3 is linked to Alzheimer disease.